Position in KYTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,677,534
+$3,099,866 QoQ
Shares Held
1,005,508
+69.5% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,468,729,571 across 342 Biotechnology names. KYTX ranks #119 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in KYTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,677,534 | 1,005,508 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,577,668 | 593,369 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,309,810 | 551,635 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,389,359 | 452,560 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $459,801 | 238,239 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,791,988 | 746,521 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,129,888 | 1,253,556 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,923,115 | 923,082 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $17,266,134 | 695,094 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||